Estimating the prevalence of phosphodiesterase-5 inhibitor users bypassing the healthcare system in Europe

被引：0
|
作者：
Kirby, M. [1 ]
Banks, I [2 ]
Zou, K. [3 ]
Schnetzler, G. [4 ]
Symonds, T. [5 ]
机构：
[1] Univ Hertfordshire, Hatfield AL10 9AB, Herts, England
[2] Leeds Metropolitan Univ, Leeds LS1 3HE, W Yorkshire, England
[3] Pfizer Inc, New York, NY USA
[4] Prism Ideas Ltd, Basel, Switzerland
[5] Pfizer Ltd, Sandwich CT13 9NJ, Kent, England
来源：
JOURNAL OF SEXUAL MEDICINE | 2009年 / 6卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：416 / 417
页数：2
相关论文
共 50 条
  • [31] Influence of the phosphodiesterase-5 inhibitor, sildenafil, on sensitivity to chemotherapy in breast tumor cells
    Xu Di
    Chris Gennings
    Harry D. Bear
    Laura J. Graham
    Christopher M. Sheth
    Kimber L. White
    David A. Gewirtz
    Breast Cancer Research and Treatment, 2010, 124 : 349 - 360
  • [32] Influence of the phosphodiesterase-5 inhibitor, sildenafil, on sensitivity to chemotherapy in breast tumor cells
    Di, Xu
    Gennings, Chris
    Bear, Harry D.
    Graham, Laura J.
    Sheth, Christopher M.
    White, Kimber L., Jr.
    Gewirtz, David A.
    BREAST CANCER RESEARCH AND TREATMENT, 2010, 124 (02) : 349 - 360
  • [33] Effects Of The Phosphodiesterase-5 Inhibitor Tadalafil On Parameters Of Aerobic Fitness In Healthy Men
    Buzzachera, Cosme Franklim
    Emerenziani, Gian Pietro
    Franciosi, Emanuele
    Gallotta, Maria Chiara
    Di Luigi, Luigi
    Guidetti, Laura
    Baldari, Carlo
    MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 2012, 44 : 443 - 443
  • [34] A NON-SYSTEMIC PHOSPHODIESTERASE-5 INHIBITOR SUPPRESSES COLON PROLIFERATION IN MICE
    Islam, Bianca N.
    Lee, Avelina
    Lebedyeva, Iryna
    Browning, Darren D.
    GASTROENTEROLOGY, 2022, 162 (07) : S952 - S952
  • [35] Tadalafil, a Phosphodiesterase-5 Inhibitor, Improves Erectile Dysfunction in Patients With Liver Cirrhosis
    Thakur, Jitender
    Rathi, Sahaj
    Grover, Sandeep
    Chopra, Madhu
    Agrawal, Swastik
    Taneja, Sunil
    Duseja, Ajay
    Bhansali, Anil
    Chawla, Yogesh K.
    Dhiman, Radha K.
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2019, 9 (03) : 312 - 317
  • [36] ASSESSMENT OF HEADACHE IN MEN TAKING PHOSPHODIESTERASE-5 INHIBITOR (TADALAFIL) FOR ERECTILE DYSFUNCTION
    Okuyucu, E. Esra
    Guven, Oguz
    Ucar, Edip
    Duman, Taskin
    ACTA MEDICA MEDITERRANEA, 2014, 30 (05): : 1007 - 1011
  • [37] Positive effect of tadalafil, a phosphodiesterase-5 inhibitor, on fracture healing in rat femur
    Togral, Guray
    Arikan, S. Murat
    Korkusuz, Petek
    Hesar, Ramin Hashemi
    Eksioglu, M. Fatih
    EKLEM HASTALIKLARI VE CERRAHISI-JOINT DISEASES AND RELATED SURGERY, 2015, 26 (03): : 137 - 144
  • [38] A Non-Systemic Phosphodiesterase-5 Inhibitor Suppresses Colon Proliferation in Mice
    Lee, Avelina
    Lebedyeva, Iryna
    Zhi, Wenbo
    Senthil, Vani
    Cheema, Herjot
    Brands, Michael W.
    Bush, Weston
    Lambert, Nevin A.
    Snipes, Madeline
    Browning, Darren D.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (11)
  • [39] LONG-TERM PHOSPHODIESTERASE-5 INHIBITOR THERAPY PREVENTING PRIAPISM RECURRENCES
    Nardozza, Archimedes, Jr.
    Coelho, Mariana Andrade
    Oliveira, Frederico V.
    Kobaz, Alberto K.
    Alarcon, Gustavo
    Offerni, Juliano C. M.
    Cabrini, Marcelo R.
    Ortiz, Valdemar
    JOURNAL OF UROLOGY, 2009, 181 (04): : 528 - 529
  • [40] The phosphodiesterase-5 inhibitor vardenafil improves cardiovascular dysfunction in experimental diabetes mellitus
    Radovits, T.
    Boemicke, T.
    Koekeny, G.
    Arif, R.
    Loganathan, S.
    Kecsan, K.
    Korkmaz, S.
    Barnucz, E.
    Sandner, P.
    Karck, M.
    Szabo, G.
    BRITISH JOURNAL OF PHARMACOLOGY, 2009, 156 (06) : 909 - 919
12345